Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Did You Know Previous | All Articles This Week | Next
This article originally posted 20 July, 2011 and appeared in  DietType 2 DiabetesPreventionIssue 583

Onion Skins Help Reduce Diabetes Risk

According to the results of a new study, onion skins have now joined the list of things that could offer potential benefits for people with type 2 diabetes. The study, at the University of Madrid found that the brown skin and external layers of onions contain useful amounts of fiber and flavonoids, and that the bulbs contain sulphurous compounds and fructans. The research showed that because the brown skin of the onion was high in dietary fiber it could be used as a functional ingredient, and that two outer fleshy layers also contain flavonoids, and have a high antioxidant capacity. Onion waste could be used as a natural source of ingredients with high functional value, because this vegetable is rich in compounds that provide benefits for human health. Plant Foods for Human Nutrition July 2011

Advertisement
Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 20 July, 2011 and appeared in  DietType 2 DiabetesPreventionIssue 583

Past five issues: Diabetes Clinical Mastery Series Issue 203 | Issue 743 | Diabetes Clinical Mastery Series Issue 202 | SGLT-2 Inhibitors Special Edition August 2014 | GLP-1 Special Editions August 2014 |

2014 Most Popular Articles:

Low-carb Diet Recommended for Type 1 and 2 Diabetes Patients
Posted August 01, 2014
New Combination of Diabetes Drugs Have Synergistic Effect
Posted August 08, 2014
New Encapsulated Beta-Cell Replacement Therapy for Type 1 Diabetes
Posted August 08, 2014
FDA Approves J&J's Invokamet Combo (SGLT-2 + Metformin)
Posted August 15, 2014
During Prolonged Low-Intensity Exercise, Caffeine Alters Blood Glucose
Posted August 15, 2014
HbA1c Increases with Age
Posted August 01, 2014
SGLT2 Inhibitor Empagliflozin Wins FDA OK
Posted August 08, 2014
Diabetic Neuropathy Improved with Vegan Diet
Posted August 22, 2014
New Way to Regenerate Beta Cells in Type 1 Diabetes Patients
Posted August 08, 2014
Statin Adherence Linked to New Onset Diabetes Risk
Posted July 25, 2014


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Bernstein | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
Do you recommend SGLT-2 drugs for type 1 diabetes?
CME/CE of the Week
NEW! How Do We Optimize with Antiplatelet and Anticoagulant Therapies? 
from the Acute Coronary Education Summit - July 27-28, 2011

Category: Cardiology
Time: 240 minutes



Search Articles On Diabetes In Control